Washington University in St. Louis study finds IMRT has less harmful rectal side effects than 3D-CRT for prostate cancer patients:

Washington University in St. Louis study finds IMRT has less harmful rectal side effects than 3D-CRT for prostate cancer patients: NCI Cancer Center News Men with localized prostate cancer treated with a newer technology, intensity modulated radiation therapy (IMRT), have more than a quarter (26 percent) fewer late bowel and rectal side effects and a statistically … Continue reading “Washington University in St. Louis study finds IMRT has less harmful rectal side effects than 3D-CRT for prostate cancer patients:”

Washington University in St. Louis study finds IMRT has less harmful rectal side effects than 3D-CRT for prostate cancer patients: NCI Cancer Center News

Men with localized prostate cancer treated with a newer technology, intensity modulated radiation therapy (IMRT), have more than a quarter (26 percent) fewer late bowel and rectal side effects and a statistically improved lower dose of radiation to the bladder and rectum, compared to those who undergo 3D-CRT, according to a randomized study to be presented at the plenary session October 3, 2011, at the 53rd Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Click here to read full press release from Washington University Medical Center.

###

Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Author: Joe Lovrek

Born in Houston, Raised in Trinity Texas

Leave a Reply